Evaluating the Use of Two Different Needles in Subjects With Diabetes

Novo Nordisk A/S119 enrolled

Overview

This trial is conducted in Europe. The aim of this trial is to compare two needle types when used with a disposable insulin injection pen in the everyday life setting of an insulin treated patient with diabetes.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

119

Conditions

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Delivery Systems

Interventions

NovoFine® needle 6 mmDEVICE

NovoFine® needle 8 mmDEVICE

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Signed and dated informed consent obtained before any trial-related activities * Diagnosed type 1 or type 2 diabetes * Treated with insulin Exclusion Criteria: * Previous participation in this trial * Mental incapacity, unwillingness or language barriers precluding adequate understanding or co-operation * Any disease or condition which the investigator feels would interfere with the trial

Locations (10)

Novo Nordisk Investigational Site

Cambridge, United Kingdom

Novo Nordisk Investigational Site

Cardiff, United Kingdom

Novo Nordisk Investigational Site

Church Village, United Kingdom

Outcomes

Primary Outcomes

Overall needle preference

Time frame: after 2-3 weeks of treatment

Secondary Outcomes

Injection pressure

Pain perception

Handling and acceptance of needles

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.